Mr. Damian Kettlewell of Blissco reports

BLISSCO RECEIVES DRIED CANNABIS FROM ECOSYSTEM PARTNER SUPREME FOR SALES LICENSE AMENDMENT APPLICATION TO SERVE $200 BILLION MEDICAL EXPORT MARKET

Just days after news of legalization in Canada, Blissco Cannabis Corp. is receiving a supply of premium dried cannabis from The Supreme Cannabis Company Inc. this week.

This dried cannabis will enable Blissco to apply for a sales amendment to its ACMPR (Access to Cannabis for Medical Purposes Regulations) licence for the purpose of supplying its domestic and global ecosystem partners in nations where medical cannabis is federally legal.

It is estimated that the global market for medical cannabis exports could be worth $200-billion. Statistics Canada also estimated that $1.2-billion of illegal cannabis was exported in 2017 alone.

"We are right on schedule with the submission of this application to receive an amendment to our ACMPR licence to permit us to begin sales in late September," said Damian Kettlewell, chief executive officer of Blissco Cannabis. "The transition to significant revenue growth is the key milestone that we have been focused on as we have laid the groundwork for almost five years. We continue to make positive steps towards realizing our vision of creating an iconic Canadian cannabis brand."

This cannabis will be packaged into five-, 10- and 30-gram containers, which will allow Blissco to, in mid-July, apply for an amendment to its ACMPR licence to allow dried cannabis sales in domestic markets and apply for export permits for international markets.

Additionally, Blissco's ecosystem has initiated the exploration of business development plans that will continue to develop the company's global network of strategic alliances, ultimately supporting the company's efforts to foster relationships in the international market.

"We have been watching the development of Blissco for some time and have been impressed by Mr. Kettlewell's retail and distribution strength, industry connectivity, and vision for the cannabis industry in British Columbia and Western Canada," said John Fowler, chief executive officer of Supreme Cannabis. "Like Supreme, British Columbians have a passion for high-quality cannabis, and we look forward to [continuing our work with] Mr. Kettlewell and his team at Blissco."

About Blissco Cannabis Corp.

Blissco Cannabis owns, through its wholly owned subsidiary, Blissco Holdings Ltd., a licence to produce marijuana under the ACMPR, which was originally granted on March 29, 2018.

Blissco began growing medical cannabis in early May, 2018, and applied to Health Canada to amend its ACMPR licence to include cannabis oil production in early June, 2018.

Blissco is projected to have a sales licence inspection from Health Canada in August, 2018, and earn a sales licence in late September to sell dried cannabis.

We seek Safe Harbor.